3 Biotechs That Will Crush the Bear

It's been an ugly year in the stock market so far, and both good and bad stocks have been hammered. Now's a great time to go shopping if you have the cash. Our roundtable has three biotech stocks that could be worth significantly more over the next three years than they are right now.

Here's why they like Doximity (NYSE: DOCS), Outset Medical (NASDAQ: OM) and Pieris Pharmaceuticals (NASDAQ: PIRS) to wallop the stock market.

Image source: Getty Images.

Continue reading

Source Fool.com